Biomedical technology

Consortium advances a test to detect drug-induced liver injury

Researchers from Critical Path Institute's (C-Path) Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for detecting liver injury, supporting clearer decision-making. ...

Gastroenterology

Targeting hormones could reduce risk of fatty liver disease

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the condition, according to Yale research published in Cellular and Molecular Gastroenterology and Hepatology.

page 5 from 10